French multinational pharmaceutical company Sanofi has agreed to purchase U.S. biotech company Principia Biopharma Inc. for about $3.4 billion in an all-cash deal. As part of the deal, Sanofi will be taking full control of the company, which focuses on treatments for multiple sclerosis and a range of autoimmune disorders. Sanofi will secure drugs such … Continue reading “Sanofi Agrees to Buy Principia Biopharma Inc. for Roughly $3.4 Billion”
Biotech & Pharma
Sorrento Shares Take Steep Fall as Company Fires CFO
According to a recent Securities and Exchange Commission filing, Sorrento has terminated its CFO Jiong…
President Trump Signs $1.5B Deal with Moderna for 100 Million Doses of Coronavirus Vaccine
This week President Trump announced that the U.S. government has signed a $1.5 billion deal…
Big Pharma Giant Merck Explodes on Earnings Beat
Shares of pharmaceutical firm Merck were heading higher after the company reported second-quarter sales of…
The United States Will Pay This Much to Pfizer and BioNTech for its COVID-19 Vaccine
As coronavirus cases keep surging, the U.S. is prepared to pay a steep amount for…
AstraZeneca’s Experimental COVID-19 Vaccine Looks Promising
With coronavirus cases surging in the U.S., many may feel relief learning that AstraZeneca's experimental…
Bioxcel Therapeutics Soars to Record High on Strong Schizophrenia Test Results
Shares of biotech company Bioxcel Therapeutics soared 14% on Monday and hit an all-time intraday…
Khloe Kardashian Signs Up as Influencer for Biohaven Pharmaceuticals Migraine Drug
Biohaven Pharmaceuticals has landed reality TV star Khloe Kardashian as an influencer of a new…
Pfizer and BioNtech Are Granted FDA Fast Track Designation for SARS-COV-2 Vaccine Candidates
Pharmaceutical giant Pfizer Inc. and BionTech SE made an exciting joint announcement on Monday that…
Bayer Has Reached An Over $10B Settlement over Roundup Cancer Lawsuits
German multinational pharmaceutical and life sciences company Bayer has reached an over $10 billion settlement…
CEO of Moderna Thinks Company’s COVID-19 Vaccine is Likely to be Successful
Moderna CEO Stéphane Bancel sees ‘high probability’ of success with the company's Covid-19 vaccine. The…
Novavax to Raise Capital through $200M Stock Offering to Fund COVID-19 Vaccine
American vaccine development company Novavax announced on Monday that it would raise fresh capital through…
Novus Therapeutics Plummets After Disappointing Drug Trial Results
Shares of Novus Therapeutics were on a downward spiral on Monday, losing almost half of…
Arca Biopharma Explodes Higher After Announcing Plans to Test a Coronavirus Drug
Shares of Arca Biopharma were skyrocketing on Thursday and nearly quintupled in value after the…